Independent researcher Simon Willison raises questions about hidden Series A and B rounds, investor windfalls, and whether a key piece of Python infrastructure just became a competitive weapon in the ...

Protagonist's pipeline leverages its proprietary Vectrix platform to target obesity, hematology, and inflammation. Find out why PTGX stock is a Buy.